Shannon John Patrick Jr 4
4 · Xeris Biopharma Holdings, Inc. · Filed Aug 4, 2025
Insider Transaction Report
Form 4
Shannon John Patrick Jr
DirectorSee Remarks
Transactions
- Tax Payment
Common Stock
2025-08-01$5.38/sh−36,918$198,619→ 2,657,425 total
Footnotes (2)
- [F1]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of August 1, 2025.
- [F2]These shares include 7,225 shares that were purchased on June 30, 2025, due to participation by the reporting individual in the issuer's 2018 Employee Stock Purchase Plan